EWING SARCOMA METASTATIC
Clinical trials for EWING SARCOMA METASTATIC explained in plain language.
Never miss a new study
Get alerted when new EWING SARCOMA METASTATIC trials appear
Sign up with your email to follow new studies for EWING SARCOMA METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common drug help fight rare bone cancers?
Disease control Recruiting nowThis study tests whether adding eflornithine (DFMO) to standard chemotherapy can help teens and young adults with Ewing sarcoma or osteosarcoma live longer without their cancer coming back. About 406 participants will join one of five groups based on their cancer type and stage. …
Matched conditions: EWING SARCOMA METASTATIC
Phase: PHASE2 • Sponsor: Milton S. Hershey Medical Center • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New drug trial aims to slow rare Cancer's spread
Disease control Recruiting nowThis study tests a drug called zanzalintinib (XL092) in 29 people with advanced leiomyosarcoma that has spread or cannot be removed by surgery. The drug works by blocking signals that help cancer cells grow. The goal is to see if it can slow the cancer's progression longer than c…
Matched conditions: EWING SARCOMA METASTATIC
Phase: PHASE2 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC